Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment of Chronic Hepatitis C with ISIS 14803, An Antisense Inhibitor of HCV, Given for 12 Weeks

Treatment of Chronic Hepatitis C with ISIS 14803, An Antisense Inhibitor of HCV, Given for 12 Weeks. Hepatology. 2003; 38(4):306-7A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.